Sativex® effects on promoter methylation and on CNR1/CNR2 expression in peripheral blood mononuclear cells of progressive multiple sclerosis patients
Keywords: CNR1; cannabinoid type 1; CNR2; cannabinoid type 2; MS; multiple sclerosis; MSS-SP; MS secondary progressive patients with spasticity; PBMCs; peripheral blood mononuclear cells; IFN-β-1b; interferon-β-1b; MS-HRM; methylation sensitive high resolution me